CD8A and neoplasm: In fact, transfer of activated undifferentiated CD44low CD62L+ CD8+ T cells (referred as stem cell memory T cells (TSCM)) into tumor-bearing mice resulted in higher anti-tumor responses, compared to those found in mice receiving TEM cells [13].